SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-019355
Filing Date
2015-03-30
Accepted
2015-03-30 16:11:38
Documents
1
Period of Report
2015-03-26

Document Format Files

Seq Description Document Type Size
1 form473923_20150330041118-.html 4  
1 form473923_20150330041118-.xml 4 2955
  Complete submission text file 0001144204-15-019355.txt   4455
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O MONTAUR CAPITAL PARTNERS 152 WEST 57TH STREET, 4TH FLOOR NEW YORK NY 10019
Business Address
GOLDBERG MICHAEL M (Reporting) CIK: 0000905011 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 15734629